Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16785691 | 1.00 | DPP4 (0.53) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL16785688 | 1.00 | DPP4 (0.53) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL16785690 | 1.00 | DPP4 (0.53) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL14437828 | 1.00 | DPP4 (0.53) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL16785692 | 1.00 | DPP4 (0.53) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL144406 | 0.98 | ALDH1A1 (0.53) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL13144214 | 0.91 | DPP4 (0.46) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL23611278 | 0.86 | DPP4 (0.65) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL13707354 | 0.86 | DPP4 (0.65) | DPP4ALDH1A1KDM4EL3MBTL1MAPT | |
| Alpha-Terthienyl SCHEMBL147274 | 0.86 | DPP4 (0.65) | DPP4ALDH1A1KDM4EL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240229026-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES LTD. (SG) | 2024-07-11 | — | — | US | disclosed |
| WO-2023210569-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM, AND ORGANIC SEMICONDUCTOR ELEMENT | 東ソー株式会社 | 2023-11-02 | — | — | WO | disclosed |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| US-20230302038-A1 | RNAS FOR COMPLEMENT INHIBITION | SIXTH STREET LENDING PARTNERS | 2023-09-28 | — | — | US | disclosed |
| EP-2764034-B1 | POLYMERS BASED ON BENZODIONES | CLAP CO LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| WO-2022148752-A9 | PHOTOCHROMIC DYES AND POLYMERIC MATRIX FOR AN EFFICIENT DIMMING FILM | Sony Group Corporation (JP) | 2023-08-03 | — | — | WO | disclosed |
| EP-4219516-A2 | CHIRAL CONTROL | Wave Life Sciences Ltd. (SG) | 2023-08-02 | — | — | EP | disclosed |
| US-20230212606-A1 | COMPOSITIONS AND METHODS FOR TREATING KCNQ4-ASSOCIATED HEARING LOSS | AKOUOS, INC. | 2023-07-06 | — | — | US | disclosed |
| WO-2023129496-A2 | RNAS FOR COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| WO-2001085213-A2 | SUPPORTS FOR PHOTOSENSITIZER FORMULATIONS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| US-5912473-A | Method of manufacturing organic oriented film and method of manufacturing electronic device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1999-06-15 | — | — | US | disclosed |
| US-5753692-A | PLANT EXTRACTS, IMMUNOSTIMULANTS TREATING IMMUNODEFICIENCY DISEASES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-19 | — | — | US | disclosed |
| US-5747525-A | ANTITUMOR AGENTS OF OLIGOMERS OF THIOPHENE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-05 | — | — | US | disclosed |
| US-5602170-A | ADMINISTERING ANTIIFLAMMATORY AGENT | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1997-02-11 | — | — | US | disclosed |
| US-5546889-A | Method of manufacturing organic oriented film and method of manufacturing electronic device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1996-08-20 | — | — | US | disclosed |
| US-5180838-A | Terthienyl compounds as insecticides | HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENSE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1993-01-19 | — | — | US | disclosed |
| US-5045563-A | Terthienyl Compound | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1991-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212606-A1 | COMPOSITIONS AND METHODS FOR TREATING KCNQ4-ASSOCIATED HEARING LOSS | KCNQ4, KCNQ1, KCNJ4 | DPP4 1361/4885ALDH1A1 4447/4885KDM4E 885/4885 |
| US-20240229026-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | DPP4 2127/4885ALDH1A1 2867/4885KDM4E 3578/4885 |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | POLRMT, DCLRE1B, RNGTT | DPP4 1041/4885ALDH1A1 3318/4885KDM4E 3297/4885 |
| US-20230302038-A1 | RNAS FOR COMPLEMENT INHIBITION | SNRPE, RNASE1, SNRPF | DPP4 3492/4885ALDH1A1 4397/4885KDM4E 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.